Inebilizumab: First Approval

This article summarizes the milestones in the development of inebilizumab leading to this first approval for the treatment of AQP4-IgG seropositive NMOSD.

http://link.springer.com/10.1007/s40265-020-01370-4

Source: Drugs - July 28, 2020 Category: Drugs & Pharmacology Source Type: research